China Universal Asset Management Company’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Sell
44,290
-2,979
-6% -$9.6K 0.01% 376
2026
Q1
$136K Buy
47,269
+3,865
+9% +$15.2K 0.01% 382
2025
Q4
$177K Sell
43,404
-1,943
-4% -$8.7K 0.01% 357
2025
Q3
$161K Buy
45,347
+45
+0.1% +$163 0.01% 347
2025
Q2
$124K Buy
45,302
+518
+1% +$1.07K 0.01% 346
2025
Q1
$75.2K Sell
44,784
-2,557
-5% -$7.15K 0.01% 382
2024
Q4
$77.2K Buy
47,341
+4,554
+11% +$13.6K 0.01% 418
2024
Q3
$178K Buy
42,787
+16,764
+64% +$88.1K 0.02% 311
2024
Q2
$142K Sell
26,023
-16,377
-39% -$130K 0.02% 275
2024
Q1
$424K Buy
42,400
+19,600
+86% +$147K 0.05% 200
2023
Q4
$93K Buy
22,800
+17,753
+352% +$65.4K 0.02% 292
2023
Q3
$19.5K Buy
5,047
+2,537
+101% +$13.6K 0.01% 301
2023
Q2
$15K Sell
2,510
-74
-3% -$426 ﹤0.01% 292
2023
Q1
$8.45K Buy
2,584
+646
+33% +$2.58K ﹤0.01% 315
2022
Q4
$7.66K Buy
1,938
+157
+9% +$768 ﹤0.01% 253
2022
Q3
$11K Buy
+1,781
New +$12.9K ﹤0.01% 199

Other funds holding SANA

China Universal Asset Management Company's SANA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Sana Biotechnology (SANA) stake by 6.3% in Q2 2026, selling an estimated $9.6K and leaving 44,290 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #376.

China Universal Asset Management Company first reported a position in SANA in Q3 2022 and has held it in 16 quarters since. The position peaked at $424K in Q1 2024. 28 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • China Universal Asset Management Company held 44,290 shares of Sana Biotechnology worth $155K as of Q2 2026.
  • China Universal Asset Management Company sold 2,979 Sana Biotechnology shares in Q2 2026, an estimated $9.6K.
  • Sana Biotechnology made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #376 holding.
  • China Universal Asset Management Company first reported a position in Sana Biotechnology in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Sana Biotechnology position peaked at $424K in Q1 2024.
  • 28 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.